Evidence map›Paper›PMID 42129542›Full record

ReviewThe EMBO journal2026

Host-transposable element coexistence: a matter of resistance, tolerance and trade-off.

Séverine Chambeyron, Alain Pélisson, Yuica Koga, Charlotte Grimaud, Mikiko C Siomi

Abstract readReview
In one paragraph

Review in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Séverine ChambeyronInstitute of Human Genetics (IGH), Univ Montpellier, CNRS, Montpellier, France. severine.chambeyron@igh.cnrs.fr.ORCID http://orcid.org/0000-0003-2775-6556
Alain PélissonInstitute of Human Genetics (IGH), Univ Montpellier, CNRS, Montpellier, France.
Yuica KogaDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Charlotte GrimaudInstitute of Human Genetics (IGH), Univ Montpellier, CNRS, Montpellier, France. charlotte.grimaud@igh.cnrs.fr.ORCID http://orcid.org/0000-0001-7944-5931
Mikiko C SiomiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan. siomim@bs.s.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-6149-4396

Funding

Agence Nationale de la Recherche (ANR) ANR-24-CE12-5869-01Fondation pour la Recherche Médicale (FRM) EQU202303016294MEXT | | Advanced Science Institute (ASI) 25H01303
6 · The paper itself

Abstract

Transposable elements (TEs) are ubiquitous, mobile DNA elements that often exist as multiple copies within host genomes. To persist despite ongoing mutational decay, these genomic parasites must continuously generate new insertions into the germline genome, a process that risks compromising host reproductive capacity by disrupting coding regions and regulatory sequences and by reshaping chromosomal architecture. Accordingly, hosts have evolved mechanisms to repress TE activity and reduce its fitness costs. In principle, however, such antagonism could lead to lineage-specific TE extinction, which may be suboptimal for hosts, as TEs possess aspects that confer beneficial functions to them. Therefore, hosts not only resist but also tolerate and even exploit the presence of TEs. In parallel, TEs themselves have acquired and deployed unique strategies that promote their own persistence while limiting harm to the host. This review explores how "peaceful" coexistence between hosts and TEs is achieved, focusing on resistance, tolerance, and the associated trade-offs from both host and TE perspectives.

Indexed as

DNA Transposable ElementsAnimalsEvolution, MolecularHumansDNA Transposable Elements

Identifiers

PMID42129542
PMCPMC13269885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.